Maralixibat Suppliers & Bulk Manufacturers
Available Forms: Oral Solution
Available Strengths: 380 µg/mL
Reference Brands: Livmarli (USA/EU)
Category: Medical Aid
Maralixibat (Livmarli) is used to treat progressive familial intrahepatic cholestasis (PFIC) in pediatric patients. It works by inhibiting the ileal bile acid transporter (IBAT), reducing bile acid reabsorption in the intestine, decreasing systemic bile acid levels, and improving liver function and pruritus (itching) associated with cholestatic liver disease. Maralixibat is available in Oral Solution and strengths such as 380 µg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Maralixibat is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Maralixibat can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Maralixibat is used to treat cholestatic pruritus in patients with rare liver diseases, such as Alagille syndrome.
Maralixibat is a small-molecule ileal bile acid transporter (IBAT) inhibitor that reduces bile acid reabsorption in the intestine.
The trade name is Livmarli.
Livmarli is manufactured by Mirum Pharmaceuticals.
The generic name is maralixibat.
The brand name is Livmarli.
It is manufactured in the United States by Mirum Pharmaceuticals.
Related Products
Lofexidine Hydrochloride
Strength:
0.18 mg
Form: Tablets
Reference Brands: Lucemyra (USA)
View Details
Chlorhexidine Solutions
Strength:
0.12% or 2%
Form: Solutions for disinfection
Reference Brands: Peridex, Periogard(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
